Risk group assessment and clinical outcome algorithm to predict the natural history of patients with surgically resected renal cell carcinoma. - Wikidata - awgldk - TriplyDB

Risk group assessment and clinical outcome algorithm to predict the natural history of patients with surgically resected renal cell carcinoma.

Risk group assessment and clinical outcome algorithm to predict the natural history of patients with surgically resected renal cell carcinoma.

http://www.wikidata.org/entity/Q35009888

about

Immunotherapy for metastatic renal cell carcinoma Podoplanin associates with adverse postoperative prognosis of patients with clear cell renal cell carcinoma Crosstalk between Long Noncoding RNAs and MicroRNAs in Health and Disease Prognostic Significance of Hypoxia-Inducible Factor Expression in Renal Cell Carcinoma: A PRISMA-compliant Systematic Review and Meta-Analysis Percutaneous biopsy for risk stratification of renal masses Positive intratumoral chemokine (C-C motif) receptor 8 expression predicts high recurrence risk of post-operation clear-cell renal cell carcinoma patients Immunotherapy for metastatic renal cell carcinoma.Staging of renal cell carcinoma: Current concepts.Clinico-pathological prognostic factors of renal cell carcinoma: A 15-year review from a single center in Greece Evaluating overall survival and competing risks of death in patients with localized renal cell carcinoma using a comprehensive nomogram Enhancer of zeste homolog 2 (EZH2) expression is an independent prognostic factor in renal cell carcinoma ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma High NUCB2 expression level represents an independent negative prognostic factor in Chinese cohorts of non-metastatic clear cell renal cell carcinoma patients Serum level and immunohistochemical expression of vascular endothelial growth factor for the prediction of postoperative recurrence in renal cell carcinoma.Analysis of lymph node dissection in patients with ≥7-cm renal tumors.Decreasing rates of lymph node dissection during radical nephrectomy for renal cell carcinoma.Pretherapeutic gamma-glutamyltransferase is an independent prognostic factor for patients with renal cell carcinoma.Clinical significance of heparanase splice variant (t5) in renal cell carcinoma: evaluation by a novel t5-specific monoclonal antibody RUNX3 suppresses migration, invasion and angiogenesis of human renal cell carcinoma.Evaluation of the National Comprehensive Cancer Network and American Urological Association renal cell carcinoma surveillance guidelines Inhibition of angiogenic and non-angiogenic targets by sorafenib in renal cell carcinoma (RCC) in a RCC xenograft model Whole genome SNP arrays as a potential diagnostic tool for the detection of characteristic chromosomal aberrations in renal epithelial tumors.Prognostic value of preoperative neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios, and multiphasic renal tomography findings in histological subtypes of renal cell carcinoma.p42.3 promotes cell proliferation and invasion in human Renal-Cell Carcinoma.Recent developments in kidney cancer RETRACTED: Management of small renal masses--update 2011.Increased expression of colony stimulating factor-1 is a predictor of poor prognosis in patients with clear-cell renal cell carcinoma.Tumor necrosis on magnetic resonance imaging correlates with aggressive histology and disease progression in clear cell renal cell carcinoma Serum amino acid levels as a biomarker for renal cell carcinoma.Expression of IL-4 and IL-13 predicts recurrence and survival in localized clear-cell renal cell carcinoma.Clinical and prognostic factors for renal parenchymal, pelvis, and ureter cancers in SEER registries: collaborative stage data collection system, version 2 The relationship between the preoperative systemic inflammatory response and cancer-specific survival in patients undergoing potentially curative resection for renal clear cell cancer Long-term survival rates after resection for locally advanced kidney cancer: Memorial Sloan Kettering Cancer Center 1989 to 2012 experience.Expression of CIP2A in renal cell carcinomas correlates with tumour invasion, metastasis and patients' survival.High expression of interleukin-11 is an independent indicator of poor prognosis in clear-cell renal cell carcinoma Tumor miR-125b predicts recurrence and survival of patients with clear-cell renal cell carcinoma after surgical resection.Molecular classification of renal tumors by gene expression profiling.Serum 20S proteasome is elevated in patients with renal cell carcinoma and associated with poor prognosis.Prognostic significance of ST3GAL-1 expression in patients with clear cell renal cell carcinoma Vaccination immunotherapy--an update.

P2860

Q24186688-784AA4AF-D1C1-4552-8DFE-3D6CEBAEFEB7 Q26743903-6C644117-757F-41CD-AD27-34EF5272F619 Q26765464-77252124-012A-4DD6-9CAE-B857CFFEC54F Q26781470-120D397F-54F8-4BBA-89B6-0DF8D4C62799 Q26783525-83E48AAC-4714-4705-991B-4414042F15DA Q28602010-11BB0DDB-9E65-4DAC-AAE0-20D3133C535E Q30234458-88A505FC-6C46-4F86-87AF-9A4805606C47 Q33599726-F8B98A1F-AB18-41B2-901E-22120E80C700 Q33614217-BC9DC908-8463-4ADD-8E9F-123B342748CD Q33627815-F3A571D9-1A1A-4716-8C5B-BC7B160BFC48 Q33710169-50FF78AA-CB73-455A-8BA2-1B0B2D391ADE Q33758217-B86F508C-D050-4D6C-AFCC-B2CDB8724282 Q33798805-EA5F570B-52D1-49F1-B672-58E0AF5F7D1B Q33811628-1808969F-8C6A-400B-965B-91593B4F5B9A Q34028672-F243B64F-3AE2-4BD4-8649-F8D2040BA6D3 Q34270351-290BA84E-9569-4CF0-AFDD-FE018BA46513 Q34354554-EE435093-2A21-4EBC-9368-6692BA73BE68 Q34516760-53F8A2C8-EF8B-49DE-B630-7DCF1DCCE1CA Q34606632-C7BE170D-AD7F-4FD3-8FC7-1A29324ED1AF Q34692256-6CAB8DD1-027D-4F4B-BA3F-0BFBDB2564A1 Q34727359-11C168EF-917A-46A3-9DBB-55416248A154 Q34745214-454FE75C-95AD-4603-A0F9-71A0472DD126 Q34793982-5153FB13-BE59-4611-A1D7-0A6F37B19DB6 Q35017015-15CD8426-3A43-4138-9AD8-9CDF46FAC3DF Q35042440-C89CA912-D1B6-4926-9E1F-E029D93588AA Q35071185-7C59A5CD-CC64-404D-B829-EB8F7C8FDF83 Q35118187-F8F5641A-5598-4608-B2C6-B89E5C9E42B4 Q35190220-9B0CE1A7-8F52-404F-B621-94B4B42DAA96 Q35234267-2226C51C-5509-4D5C-8B57-5D2A1F83A9BD Q35405080-B67F6312-987B-46C4-B695-E88922737FD4 Q35439990-3BBB148A-4FA7-4639-815A-3FA0FE2934AB Q35551037-CDDEC881-AB13-4CA1-9794-806D66895697 Q35630107-CE70BA4A-AE73-46F4-94BD-3203BEFF06F1 Q35653981-B0B2E417-9D5B-405E-947B-199933648A10 Q35674197-A12544E4-3DBA-47D0-B8C2-8FF442EC1DD3 Q35713525-26ABC5FB-8C0A-444B-ACB0-76644F530730 Q35789932-5759FB14-3ACC-447A-A101-B53804DC9709 Q35835132-A3C93C35-9E19-4814-9136-9C8A7CD555EB Q35836524-8DCDE7A4-87D7-4417-96D7-5CCE72E74E62 Q35851700-748FB90B-A27B-4879-81E6-91BC16B2606C

P2860

Risk group assessment and clinical outcome algorithm to predict the natural history of patients with surgically resected renal cell carcinoma.

http://www.wikidata.org/entity/Q35009888

description

2002 nî lūn-bûn

@nan

2002 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Risk group assessment and clin ...... resected renal cell carcinoma.

@ast

Risk group assessment and clin ...... resected renal cell carcinoma.

@en

type

label

Risk group assessment and clin ...... resected renal cell carcinoma.

@ast

Risk group assessment and clin ...... resected renal cell carcinoma.

@en

prefLabel

Risk group assessment and clin ...... resected renal cell carcinoma.

@ast

Risk group assessment and clin ...... resected renal cell carcinoma.

@en

P1433

Q35009888-BD801BBB-A088-4296-8A69-5250EDE9ED82

P1476

Q35009888-8AD4DB8B-93BE-4D10-9377-10CAD532E6B1

P2093

Q35009888-1C24AB32-7B62-4ECD-82A4-1D3FDA71133B

Q35009888-2BF32225-94B3-417F-A956-CDD8AF3CEEC7

Q35009888-36E2D111-28EA-49BF-95A9-8C6125173FD4

Q35009888-40C360AF-CEFB-46BA-91E8-2023DD3740AA

Q35009888-4B56763C-2DB0-4363-B26B-F262E4C90DF6

Q35009888-8CFC753F-37D0-4865-B715-47572146E230

Q35009888-91E5492E-E283-4469-91F6-DA26D2947596

Q35009888-C87146A1-8F22-42BC-84DE-C43AC3A53CD9

Q35009888-D5571367-9683-42F7-939C-D3E696ED2E39

P304

Q35009888-202493A5-AFF7-4908-AC9C-D79E96DBAA96

P31

Q35009888-0EF9F835-DDBE-4669-BD15-981D843B6E24

P356

Q35009888-D6452E0B-B8EA-4BE4-9523-B01233C07EA1

P407

Q35009888-1CD70461-9BCF-4A14-BF40-9780FE358870

P433

Q35009888-DC92582A-E66F-41F8-8FC3-DD38AA1BC829

P478

Q35009888-8974F4B7-10BE-4E79-855E-9916CE24C21E

P577

Q35009888-D840A4CF-5A4E-45B7-9C92-FBFB527E3DE6

P698

Q35009888-E5912D54-9DB7-465B-8636-02B047ED4A1E

P921

Q35009888-15A61F88-A9AF-4E0A-B787-7FF095125371

P356

JCO.2002.05.111

P1433

Journal of Clinical Oncology

P1476

Risk group assessment and clin ...... resected renal cell carcinoma.

@en

P2093

Allan J Pantuck

http://www.w3.org/2001/XMLSchema#string

Amnon Zisman

http://www.w3.org/2001/XMLSchema#string

Arie S Belldegrun

http://www.w3.org/2001/XMLSchema#string

Debby H Chao

http://www.w3.org/2001/XMLSchema#string

Fredrick Dorey

http://www.w3.org/2001/XMLSchema#string

Jean B deKernion

http://www.w3.org/2001/XMLSchema#string

Jeffery Wieder

http://www.w3.org/2001/XMLSchema#string

Jonathan W Said

http://www.w3.org/2001/XMLSchema#string

Robert A Figlin

http://www.w3.org/2001/XMLSchema#string

P304

4559-4566

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1200/JCO.2002.05.111

http://www.w3.org/2001/XMLSchema#string

P407

P433

23

http://www.w3.org/2001/XMLSchema#string

P478

20

http://www.w3.org/2001/XMLSchema#string

P577

2002-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12454113

http://www.w3.org/2001/XMLSchema#string

P921